Victor Kouassi – Page 6 – REVIVE

About Victor Kouassi

This author has not yet filled in any details.
So far Victor Kouassi has created 157 blog entries.

Building Medtech Companies: Learn how to attract investment to fund product development and scale your company — 3 September 2020
Building Medtech Companies: Learn how to attract investment to fund product development and scale your company
more

How do we simultaneously manage the acute COVID-19 pandemic and escalating antibiotic resistance?

more

Antimicrobial Surveillance and consumption data – how, what and why to measure to provide meaningful data — Antimicrobial Surveillance and consumption data – how, what and why to measure to provide meaningful data
more

<br>Knowledge sharing for antimicrobial research: AntibioticDB and SPARK and why researchers should use them</br><em> – by Jack Stone and Maria Laura Ciusa</em> — 5 August 2020
Knowledge sharing for antimicrobial research: AntibioticDB and SPARK and why researchers should use them – by Jack Stone and Maria Laura ...
more

Navigating MedTech Regulation Pathways in Developed and Emerging Markets — 20 July 2020
Navigating MedTech Regulation Pathways in Developed and Emerging Markets
more

<br>Getting the most out of antimicrobial surveillance</br><em> – by Mariana Castanheira</em> — 28 May 2020
Getting the most out of antimicrobial surveillance – by Mariana Castanheira
more

CARB-X – How to Prepare for an FDA Pre-IND Meeting: Planning for Success — 18 May 2020
CARB-X – How to Prepare for an FDA Pre-IND Meeting: Planning for Success
more

How to use the Global AMR R&D Hub’s Dynamic Dashboard — How to use the Global AMR R&D Hub’s Dynamic Dashboard
more

<br>COVID-19 and antimicrobial resistance: Are there any unknowns that will become known?</br><em> – by Stephan Harbarth</em> — 13 May 2020
COVID-19 and antimicrobial resistance: Are there any unknowns that will become known? – by Stephan Harbarth
more

<br>COVID-19 and its impact on antimicrobial stewardship</br><em> – by Andrew Seaton</em> — 30 April 2020
COVID-19 and its impact on antimicrobial stewardship – by Andrew Seaton
more